Folfirinox
Showing 1 - 25 of 321
Pancreatic Ductal Adenocarcinoma Trial (OT-101, FOLFIRINOX)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- OT-101
- FOLFIRINOX
- (no location specified)
Oct 5, 2023
Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- Oligometastatic Disease
- FOLFIRINOX chemotherapy
-
Baltimore, MarylandJohns Hopkins Hospital
Nov 2, 2023
Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- Devimistat
- Modified FOLFIRINOX
-
Ann Arbor, MichiganRogel Cancer Center
Jun 26, 2023
Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)
Not yet recruiting
- Metastatic Pancreatic Cancer
- FOLFIRINOX treatment
- (no location specified)
Aug 9, 2023
Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Seoul (Bevacizumab + modified FOLFIRINOX)
Recruiting
- Mucinous Ovarian Cancer
- +2 more
- Bevacizumab + modified FOLFIRINOX
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Dec 25, 2022
Resectable Pancreatic Cancer Trial in Tianjin (AG Followed by FOLFIRINOX)
Recruiting
- Resectable Pancreatic Cancer
- AG Followed by FOLFIRINOX
-
Tianjin, Tianjin, ChinaRui Liu
Jan 8, 2023
Pancreatic Ductal Adenocarcinoma Trial in Houston (Pembrolizumab, Folfirinox)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Pembrolizumab
- Folfirinox
-
Houston, Texas
- +1 more
Dec 15, 2022
Rectal Cancer, Locally Advanced Trial in Tunis (Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan),
Active, not recruiting
- Rectal Cancer
- Locally Advanced
- Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
- Radiotherapy
-
Tunis, TunisiaAmel Mezlini
May 19, 2023
Metastatic Colorectal Cancer Trial in France (Folfirinox + regorrafenib)
Active, not recruiting
- Metastatic Colorectal Cancer
- Folfirinox + regorrafenib
-
Nice, Alpes-Maritimes, France
- +3 more
Jan 16, 2023
Locally Advanced Pancreatic Cancer Trial (FOLFIRINOX chemo, OncoSil™)
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- FOLFIRINOX chemotherapy
- OncoSil™
- (no location specified)
Jul 18, 2022
Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- FOLFIRINOX
- +9 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Aug 19, 2022
Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (Eryaspase,
Active, not recruiting
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- Metastatic Pancreatic Ductal Adenocarcinoma
- Eryaspase
- FOLFIRINOX
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Aug 3, 2022
GastroEsophageal Cancer Trial in Boston (Irinotecan, Oxaliplatin, Leucovorin)
Active, not recruiting
- GastroEsophageal Cancer
- Irinotecan
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 7, 2022
ADjuvant chemotherAPy After Curative Intent resecTion of
Recruiting
- Ampullary Adenocarcinoma
- Folfirinox
- Capox
-
Brescia, BS, ItalyFondazione Poliambulanza
Oct 3, 2023
Cancer Of Pancreas Trial (Analyze of GemCore status)
Not yet recruiting
- Cancer Of Pancreas
- Analyze of GemCore status
- (no location specified)
Sep 19, 2023
Pancreatic Cancer Trial (Chemotherapy, Radiation)
Active, not recruiting
- Pancreatic Cancer
- Chemotherapy
- Radiation
- (no location specified)
May 30, 2022
Metastatic Pancreatic Cancer Trial in Philadelphia (FOLFIRINOX)
Recruiting
- Metastatic Pancreatic Cancer
- FOLFIRINOX
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Sep 26, 2022
Pancreatic Cancer Trial in Cleveland (CPI 613, Oxaliplatin, Irinotecan)
Active, not recruiting
- Pancreatic Cancer
- CPI 613
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 14, 2022
Pancreatic Cancer Trial in United States (drug, radiation, procedure)
Active, not recruiting
- Pancreatic Cancer
- FOLFIRINOX
- +4 more
-
Aurora, Colorado
- +9 more
Sep 7, 2022
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
- Cholesterol metabolism disruption
-
Quebec city, Quebec, CanadaCHU de Québec-Université Laval
Oct 17, 2022
Metastatic Pancreatic Cancer Trial in Montpellier (GABRINOX, FOLFIRINOX)
Recruiting
- Metastatic Pancreatic Cancer
- GABRINOX
- FOLFIRINOX
-
Montpellier, Hérault, FranceInstitut régional du Cancer de Montpellier
Jan 2, 2022
Metastatic Colorectal Cancer Trial in France (Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, Panitumumab, oxaliplatin,
Recruiting
- Metastatic Colorectal Cancer
- Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil
- Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, irinotecan
-
Avignon, France
- +5 more
Aug 2, 2022
Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic Trial in Boston (FOLFIRNINOX, Losartan, 9-ING-41)
Recruiting
- Pancreatic Adenocarcinoma
- Pancreatic Adenocarcinoma Metastatic
- FOLFIRNINOX
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jun 7, 2022